MENU
+Compare
GNGBY
Stock ticker: OTC
AS OF
Nov 17 closing price
Price
$22.20
Change
-$0.49 (-2.16%)
Capitalization
5.95B

GNGBY Getinge AB Forecast, Technical & Fundamental Analysis

Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings... Show more

GNGBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for GNGBY with price predictions
Nov 18, 2025

GNGBY's RSI Indicator peaks and leaves overbought zone

The 10-day RSI Indicator for GNGBY moved out of overbought territory on October 24, 2025. This could be a sign that the stock is shifting from an upward trend to a downward trend. Traders may want to look at selling the stock or buying put options. Tickeron's A.I.dvisor looked at 43 instances where the indicator moved out of the overbought zone. In of the 43 cases the stock moved lower in the days that followed. This puts the odds of a move down at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 04, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GNGBY as a result. In of 67 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GNGBY turned negative on November 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at .

GNGBY moved below its 50-day moving average on November 17, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNGBY declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GNGBY advanced for three days, in of 308 cases, the price rose further within the following month. The odds of a continued upward trend are .

GNGBY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 315 cases where GNGBY Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.924) is normal, around the industry mean (63.027). P/E Ratio (27.368) is within average values for comparable stocks, (35.851). Projected Growth (PEG Ratio) (1.019) is also within normal values, averaging (1.651). Dividend Yield (0.022) settles around the average of (0.019) among similar stocks. P/S Ratio (1.565) is also within normal values, averaging (60.827).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. GNGBY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNGBY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

View a ticker or compare two or three
GNGBY
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published Dividends

GNGBY paid dividends on May 14, 2025

Getinge AB GNGBY Stock Dividends
А dividend of $1.39 per share was paid with a record date of May 14, 2025, and an ex-dividend date of April 24, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
N/A
Address
Lindholmspiren 7A
Phone
+46 103350000
Employees
11226
Web
https://www.getinge.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
CREYX9.840.04
+0.41%
Columbia Real Estate Equity Inst3
LAMAX25.36N/A
N/A
Lord Abbett Dividend Growth A
USTCX32.48N/A
N/A
Victory Science & Technology Class A
PRPCX4.45N/A
N/A
PGIM Jennison Energy Infrastructure C
RGEBX81.95-0.57
-0.69%
American Funds Growth Fund of Amer R2E

GNGBY and Stocks

Correlation & Price change

A.I.dvisor tells us that GNGBY and CNMD have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that GNGBY and CNMD's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
N/A
CNMD - GNGBY
32%
Poorly correlated
+0.50%
ALGN - GNGBY
29%
Poorly correlated
-0.26%
AVNS - GNGBY
28%
Poorly correlated
+1.08%
SNN - GNGBY
27%
Poorly correlated
-0.09%
AEMD - GNGBY
26%
Poorly correlated
+0.74%
More

Groups containing GNGBY

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GNGBY
1D Price
Change %
GNGBY100%
N/A
Medical/Nursing Services
industry (216 stocks)
45%
Loosely correlated
-0.78%
Health Services
industry (423 stocks)
0%
Poorly correlated
-0.61%